Clinical Trial

Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging

Study acronym: REMRI
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to prospectively investigate the evolution of lesions in biparametric magnetic resonance imaging (bpMRI) of the prostate in men with no clinically significant prostate cancer (csPCa) in their initial biopsy. The main questions it aims to answer are: Does lesion progression in bpMRI predict a diagnosis of csPCa in per-protocol follow-up biopsies? What are the radiological and clinical risk factors for csPCa in per-protocol follow-up biopsies?
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-01-17; most recent amendment 2026-02-22.
Status change: Not Yet Recruiting → Recruiting 2026-02-22
Trial Details
NCT Number NCT07369570
Lead Sponsor University of Eastern Finland
Conditions Prostate Cancer (Diagnosis)
Enrollment 100 participants
Start Date 2026-02-23
Primary Completion 2027-12-31 (estimated)
Study Completion 2037-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-24